a month ago
TNYA
AnalystsWhitney IjemWhitney Ijem's Stock Forecasts
AnalystsWhitney Ijem
Sectors:
Industries:
Analyst Ranking
Bottom 10%
#4398 out of 4862 analysts
Average Return
-5.05%
Win Rate
33%27 out of 83
Risk vs Reward
Poor
Good
Whitney Ijem's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcturus Therapeutics Holdings IncARCT | +606.98% | $12.03 | $85.05 | 2020-02-06 - 2021-02-05 | Strong Buy |
Sigilon Therapeutics IncSGTX | +214.79% | $7.14 | $22.47 | 2023-01-17 - 2023-08-10 | Strong Buy |
Taysha Gene Therapies IncTSHA | +209.88% | $0.67 | $2.07 | 2023-07-05 - 2024-07-05 | Strong Buy |
Karyopharm Therapeutics IncKPTI | +111.35% | $132.15 | $279.30 | 2019-07-22 - 2020-07-23 | Strong Buy |
Rhythm Pharmaceuticals IncRYTM | +79.58% | $24.34 | $43.71 | 2023-03-01 - 2024-03-01 | Strong Buy |
Whitney Ijem Analyst Color
Get additional color on Whitney Ijem's coverage of popular stocks
5 months ago
SRPT
6 months ago
VERV
6 months ago
RYTM
a year ago
RARE
a year ago
ARCT
2 years ago
RGLS
2 years ago
SGTX
Whitney Ijem's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Verve Therapeutics IncVERV | 5 | Strong Buy | $39.00 | +715.90% | Maintains | 8 days ago |
Rhythm Pharmaceuticals IncRYTM | 6 | Strong Buy | $92.00 | +52.12% | Maintains | 15 days ago |
Alnylam Pharmaceuticals IncALNY | 8 | Strong Buy | $390.00 | +67.56% | Maintains | a month ago |
Regulus Therapeutics IncRGLS | 5 | Strong Buy | $28.00 | +1,293.03% | Maintains | a month ago |
Generation Bio CoGBIO | 2 | Strong Buy | $9.00 | +2,058.27% | Maintains | a month ago |
Tenaya Therapeutics IncTNYA | 6 | Strong Buy | $6.00 | +1,210.04% | Maintains | a month ago |
Arcturus Therapeutics Holdings IncARCT | 4 | Strong Buy | $68.00 | +518.18% | Maintains | a month ago |
Rocket Pharmaceuticals IncRCKT | 6 | Strong Buy | $36.00 | +402.09% | Maintains | 2 months ago |
Palvella Therapeutics IncPVLA | 2 | Strong Buy | $39.00 | +53.24% | Maintains | 2 months ago |
Ultragenyx Pharmaceutical IncRARE | 8 | Strong Buy | $136.00 | +284.18% | Maintains | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 8 | Hold | $424.00 | -11.21% | Upgrades | 2 months ago |
Intellia Therapeutics IncNTLA | 5 | Strong Buy | $90.00 | +1,036.36% | Maintains | 5 months ago |
Taysha Gene Therapies IncTSHA | 8 | Strong Buy | $8.00 | +451.72% | Maintains | 5 months ago |
Passage Bio IncPASG | 6 | Strong Buy | $13.00 | +3,531.28% | Maintains | 5 months ago |
Sarepta Therapeutics IncSRPT | 1 | Strong Buy | $150.00 | +171.59% | Maintains | 5 months ago |
Biomarin Pharmaceutical IncBMRN | 8 | Hold | $84.00 | +43.22% | Maintains | 6 months ago |
Sigilon Therapeutics IncSGTX | 2 | Strong Buy | $30.00 | N/A | Maintains | 2 years ago |
Neubase Therapeutics IncNBSE | 1 | Strong Buy | $260.00 | N/A | Initiates Coverage On | 5 years ago |
Karyopharm Therapeutics IncKPTI | 4 | Strong Buy | $240.00 | N/A | Upgrades | 6 years ago |
Acceleron Pharma IncXLRN | 2 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.